U.S. global health investments must continue

"A decade ago, as I was beginning my time as Senate majority leader, bipartisan consensus in Washington helped launch a new era of progress in global health just when it was sorely needed," former Sen. Bill Frist (R-Tenn.) writes in a Roll Call opinion piece. "U.S. leadership at the Global Fund [to Fight AIDS, Tuberculosis and Malaria], and bilateral health programs such as PEPFAR and the President's Malaria Initiative, signaled a renewed commitment to a core facet of our country's greatness: compassion for those most in need," Frist writes, adding, "Understanding that improving global health is good for national security, economically prudent and -- most importantly -- the right thing to do, the U.S. taxpayers made an unprecedented investment in the world's future." He states, "That investment is paying off," and goes on to highlight some of these programs' successes.

"Now is no time to shy away from our health investments," Frist continues, adding, "The U.S. investment -- less than one percent of our federal budget -- saves and transforms hundreds of thousands of lives every year. It's hard to imagine a better return on investment." "U.S. leadership has helped deliver a major blow to these three diseases," and "[w]e must finish this fight," he states. "[W]hile sweeping agreement on Capitol Hill may be rare, the same bipartisan, compassionate commitment to global health remains strong," Frist says, concluding, "Determined leadership today will help secure a stronger America and a brighter, healthier future for millions in the years to come. We have a long way to go, but together we can finally put AIDS, tuberculosis and malaria where they belong -- in the history books" (3/7).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study finds nirmatrelvir-ritonavir reduces severe COVID-19 and long COVID risks in high-risk patients